SecBot SecBot
DEFA14A ·Filed Apr 23, 2026

ACRS

Aclaris Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed6mo ago SEC0001104659-26-047263
Proxy solicitation materials
Actionable Insight • Neutral

This is a routine annual meeting with no material changes expected. Monitor for any unexpected developments in the shareholder vote.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
ACRS ▲ +22.42% at T+60d
NEUTRAL call +22.42% · α vs SPY +17.40% · entry $4.55 → $5.57
Entry = T+0 close
Apr 23, 2026
via day close
T+1d
-5.49%
call -5.49% · α -6.28%
$4.30
settled 6mo ago
T+5d
-1.76%
call -1.76% · α -3.24%
$4.47
settled 6mo ago
T+20d
-0.44%
call -0.44% · α -5.07%
$4.53
settled 5mo ago
T+60d
+22.42%
call +22.42% · α +17.40%
$5.57
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Aclaris Therapeutics, Inc. is holding its 2026 Annual Meeting of Stockholders. The meeting will be held virtually on June 4, 2026. The proposals include the election of two directors, approval of executive compensation, and ratification of the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm.

Key Financial Metrics

Vote
director election
Meeting
2026-06-04
Seats Contested
2

Key Facts

  • The 2026 Annual Meeting of Stockholders will be held virtually on June 4, 2026.
  • Proposals include the election of two directors, approval of executive compensation, and ratification of the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm.
  • The meeting materials are available online or by request.

Financial Impact

The proposals are routine and do not have a significant financial impact.

revenueepsdebtdilution

Risk Factors

  • The meeting is routine and does not pose any significant risks.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001104659-26-047263
Document: 0001104659-26-047263-index-headers.html0001104659-26-047263
Document: 0001104659-26-047263-index.html0001104659-26-047263
Document: 0001104659-26-047263.txt0001104659-26-047263
11 reports for ACRS
Performance horizon
100% Hit rate @ T+5 5 of 5 directional calls Went positive at some point 5 of 5 best @ T+60▲ +47.87%Feb 28, 2026
Filters
Rows
Reports for ACRS — sortable, filterable
TypeNow
Aug 11, 2026
10w ago
Institutional Cluster
BULLISH ★ 5/10
$5.84 $6.44▲ +10.27%▲ +10.72%$3.79 (−35.10%)
Aug 6, 2026
11w ago
8-K
NEUTRAL ★ 4/10
$6.09 $5.86▼ −3.78%▼ −4.99%$3.79 (−37.77%)
Apr 28, 2026
25w ago
8-K
BULLISH ★ 8/10
$4.22 $4.75▲ +12.56%▲ +10.87%$3.79 (−10.19%)
Apr 28, 2026
25w ago
Press Release
BULLISH ★ 7/10
$4.22 $4.75▲ +12.56%▲ +10.87%$3.79 (−10.19%)
Apr 23, 2026
26w ago
DEFA14A
NEUTRAL ★ 2/10
$4.55 $4.47▼ −1.76%▼ −3.24%$3.79 (−16.70%)
Mar 27, 2026
30w ago
Press Release
BULLISH ★ 8/10
$3.52 $3.80▲ +7.95%▲ +4.09%$3.79 (+7.67%)
Mar 20, 2026
31w ago
Press Release
NEUTRAL ★ 3/10
$3.69 $3.52▼ −4.61%▼ −2.46%$3.79 (+2.71%)
Mar 18, 2026
31w ago
Press Release
NEUTRAL ★ 5/10
$3.66 $3.59▼ −1.91%▼ −1.20%$3.79 (+3.55%)
Mar 11, 2026
32w ago
8-K
NEUTRAL ★ 3/10
$3.51 $3.74▲ +6.55%▲ +7.53%$3.79 (+7.98%)
Feb 28, 2026
34w ago
Institutional Cluster
BULLISH ★ 6/10
$3.05 $3.39▲ +11.15%▲ +12.36%$3.79 (+24.27%)
Showing 10 of 11

US Market Status

Market Open — Closes in 4h 3m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 23, 2026